Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:46 pm Purchase | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 6,686,689 12.900% | 1,099,356 (+19.68%) | View |
| 2024-11-14 09:05 am Purchase | 13G | GH Research PLC GHRS | Lynx1 Capital Management LP | 4,195,894 8.100% | 1,201,835 (+40.14%) | View |
| 2024-02-16 4:57 pm Purchase | 13G | GH Research PLC GHRS | Lynx1 Capital Management LP | 2,994,059 5.800% | 2,994,059 (New Position) | View |
| 2024-02-14 8:34 pm Sale | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II L.P. | 1,318,327 2.500% | -2,198,798 (-62.52%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 5,587,333 10.700% | 26,215 (+0.47%) | View |
| 2024-02-14 09:54 am Purchase | 13G | GH Research PLC GHRS | BIOTECHNOLOGY VALUE FUND L P | 10,400,158 19.990% | 1,125,000 (+12.13%) | View |
| 2024-02-14 07:04 am Purchase | 13G | GH Research PLC GHRS | RTW INVESTMENTS LP | 3,327,129 6.400% | 3,327,129 (New Position) | View |
| 2024-02-09 09:03 am Sale | 13G | GH Research PLC GHRS | FMR LLC | 3,136,869 6.030% | -1,319,112 (-29.60%) | View |
| 2023-03-30 5:08 pm Purchase | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 5,561,118 10.700% | 662,745 (+13.53%) | View |
| 2023-02-14 4:45 pm Purchase | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 4,898,373 9.400% | 2,054,616 (+72.25%) | View |
| 2023-02-14 4:07 pm Purchase | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II L.P. | 3,517,125 6.800% | 696,624 (+24.70%) | View |
| 2023-02-10 4:35 pm Sale | 13G | GH Research PLC GHRS | Schonharting Florian | 14,824,419 28.500% | -245,760 (-1.63%) | View |
| 2023-02-10 4:33 pm Sale | 13G | GH Research PLC GHRS | Terwey Theis H | 6,188,070 11.900% | -235,830 (-3.67%) | View |
| 2023-02-09 10:59 am Sale | 13G | GH Research PLC GHRS | FMR LLC | 4,455,981 8.565% | -746,513 (-14.35%) | View |
| 2022-05-27 4:05 pm Purchase | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II L.P. | 2,820,501 5.400% | 2,820,501 (New Position) | View |
| 2022-04-11 09:01 am Purchase | 13G | GH Research PLC GHRS | FMR LLC | 5,202,494 10.000% | 111,929 (+2.20%) | View |
| 2022-02-14 4:11 pm Sale | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 2,843,757 5.500% | -135,198 (-4.54%) | View |
| 2022-02-14 12:53 pm Purchase | 13G | GH Research PLC GHRS | BIOTECHNOLOGY VALUE FUND L P | 9,275,158 17.800% | 9,275,158 (New Position) | View |
| 2022-02-09 4:45 pm Purchase | 13G | GH Research PLC GHRS | Schonharting Florian | 15,070,179 29.000% | 15,070,179 (New Position) | View |
| 2022-02-09 4:45 pm Purchase | 13G | GH Research PLC GHRS | Terwey Theis H | 6,423,900 12.300% | 6,423,900 (New Position) | View |